ArticleNature biotechnology2026
High-resolution reconstruction of cell-type-specific transcriptional regulatory processes from bulk sequencing samples.
Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
11 authors.
Funding
Abstract
Single-cell sequencing methods such as scRNA-seq and scATAC-seq have advanced our understanding of individual cellular functions but experimentally adapting genome-wide assays measuring other genomic features to achieve single-cell resolution remains a technical challenge. Here we introduce deep-learning-based deconvolution of tissue profiles with accurate interpretation of locus-specific signals (DeepDETAILS), a quasisupervised framework performing cross-modality deconvolution using scATAC-seq reference libraries for other bulk datasets. DeepDETAILS enables base-pair-resolution mapping of genomic signals across diverse cell types, with great versatility for various omics datasets, including nascent transcript sequencing (such as PRO-cap and PRO-seq) and ChIP-seq for chromatin modifications. Using DeepDETAILS, we generated a compendium of high-resolution nascent transcription and histone modification signals across 39 diverse human tissues and 86 distinct cell types. Furthermore, we applied our compendium to fine-map risk variants associated with primary sclerosing cholangitis, a progressive cholestatic liver disorder, and revealed a potential etiology of the disease.
Identifiers
42443492What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.